ReNAgade Therapeutics Appoints Joe Bolen, Ph.D., Chief Science Innovation Officer

Contributed by: Business Wire

Logo

Tags

Biotechnology

Health

Genetics

Pharmaceutical

Oncology

Joe Bolen, Ph.D.

More Like This

ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference

ReNAgade Therapeutics to Present at the Evercore ISI 2024 Emerging Biotech Conference

CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology

ReNAgade Therapeutics to Present Preclinical Data Demonstrating Potent Extra-Hepatic Delivery of mRNA Using Proprietary Lipid Nanoparticles at 11th International mRNA Health Conference

ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting

PR Newswire associated0

Peptone Expands Leadership Team with Key Executive Hires

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer